Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Avid Bioservices, Inc. (CDMO)

15.33   0.07 (0.46%) 07-02 19:26
Open: 15.29 Pre. Close: 15.26
High: 15.705 Low: 14.843
Volume: 468,088 Market Cap: 948(M)
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 15.72 - 15.78 15.78 - 15.85
Low: 14.68 - 14.75 14.75 - 14.82
Close: 15.21 - 15.31 15.31 - 15.43

Technical analysis

as of: 2022-07-01 4:20:45 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 19.3     One year: 22.55
Support: Support1: 13.6    Support2: 11.8
Resistance: Resistance1: 16.53    Resistance2: 19.3
Pivot: 14.26
Moving Average: MA(5): 15.52     MA(20): 14.09
MA(100): 16.7     MA(250): 21.88
MACD: MACD(12,26): 0.5     Signal(9): 0.3
Stochastic oscillator: %K(14,3): 73     %D(3): 76.5
RSI: RSI(14): 58.7
52-week: High: 34.5  Low: 11.3
Average Vol(K): 3-Month: 672 (K)  10-Days: 680 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CDMO ] has closed below upper band by 31.3%. Bollinger Bands are 28.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 30 Jun 2022
How Is BioManufacturing Driving APAC CDMO Market? - BSA bureau

Thu, 30 Jun 2022
Avid Bioservices, Inc. (CDMO) Q4 2022 Earnings Call Transcript - The Motley Fool

Thu, 30 Jun 2022
Daewoong, YUWCM sign stem cell CDMO contract to treat hearing loss - KBR

Wed, 29 Jun 2022
Fujifilm's $1.6 billion CDMO investment will create 450 new jobs - FiercePharma

Wed, 29 Jun 2022
CDMO plant roundups: CRL, Batavia, OrganaBio - BioProcess Insider - BioProcess Insider

Fri, 24 Jun 2022
How a Global CDMO Overcomes Challenges in Synthesis - AZoM

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Outperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 62 (M)
Shares Float 61 (M)
% Held by Insiders 1.3 (%)
% Held by Institutions 108.1 (%)
Shares Short 6,140 (K)
Shares Short P.Month 5,190 (K)

Stock Financials

EPS 0.14
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.82
Profit Margin (%) 12.1
Operating Margin (%) 15
Return on Assets (ttm) 4.5
Return on Equity (ttm) 19.8
Qtrly Rev. Growth 44.5
Gross Profit (p.s.) 0.47
Sales Per Share 1.88
EBITDA (p.s.) 0.34
Qtrly Earnings Growth 264.7
Operating Cash Flow 27 (M)
Levered Free Cash Flow -10 (M)

Stock Valuations

PE Ratio 109.5
PEG Ratio 4.5
Price to Book value 18.46
Price to Sales 8.13
Price to Cash Flow 35.34

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2017-07-09
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.